Biological Products, Except Diagnostic Substances
Stocks Ranked by
Market Capitalization

Filters

#	Name	Market cap	Price	Price change %
1	1 Amgen AMGN $176B	$176B	$327.83	-0.61%
2	2 Gilead Sciences GILD $103B	$103B	$82.79	+2.32%
3	3 Biogen BIIB $28.5B	$28.5B	$195.98	-1.51%
4	4 Moderna MRNA $25.4B	$25.4B	$66.05	-16.84%
5	5 Vaxcyte PCVX $14.1B	$14.1B	$113.57	+0.01%
6	6 Neurocrine Biosciences NBIX $12.3B	$12.3B	$121.32	-0.01%
7	7 Bio-Techne TECH $11.4B	$11.4B	$72.09	-1.8%
8	8 Repligen RGEN $7.87B	$7.87B	$140.58	-1.97%
9	9 Halozyme HALO $7.64B	$7.64B	$60.35	+1.65%
10	10 Exelixis EXEL $7.5B	$7.5B	$26.30	-1.26%
11	11 Revolution Medicines RVMD $7.01B	$7.01B	$41.98	+0.77%
12	12 Krystal Biotech KRYS $5.72B	$5.72B	$199.03	+0.12%
13	13 Immunovant IMVT $4.24B	$4.24B	$28.98	-0.17%
14	14 ADMA Biologics ADMA $4.1B	$4.1B	$17.58	+3.9%
15	15 Arcellx ACLX $3.99B	$3.99B	$74.17	-0.31%
16	16 CRISPR Therapeutics CRSP $3.86B	$3.86B	$45.37	-0.05%
17	17 Denali Therapeutics DNLI $3.86B	$3.86B	$26.93	-0.52%
18	18 Kymera Therapeutics KYMR $2.95B	$2.95B	$45.67	+2.01%
19	19 SpringWorks Therapeutics SWTX $2.83B	$2.83B	$38.08	-1.51%
20	20 Iovance Biotherapeutics IOVA $2.82B	$2.82B	$9.30	-0.48%
21	21 Apogee Therapeutics APGE $2.82B	$2.82B	$49.73	-1.96%
22	22 Twist Bioscience TWST $2.55B	$2.55B	$43.48	-1.98%
23	23 ImmunityBio IBRX $2.5B	$2.5B	$3.60	-0.69%
24	24 CG Oncology CGON $2.41B	$2.41B	$35.97	-1.47%
25	25 Vericel Corp VCEL $2.14B	$2.14B	$43.97	+0.61%